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Several groups have investigated modification of pu-
rine nucleosides by insertion of a third ring between 
the imidazole and pyrimidine fragments. The earliest 
investigation was by Leonard and coworkers who 
described the synthesis of the benzene-stretched ade-
nosine analogue 1.1-4 Later the 2’-deoxy derivative 3 
was prepared.5 Subsequently other groups have pre-
pared tricyclic analogues6-8 and aspects of this work 
have been reviewed.9 For some time we have been 
interested in preparing pyridine-stretched purine de-
rivatives and have previously described the adenosine 
analogue 2 and the corresponding inosine analogue.10 
More recently we prepared the 2’-deoxy analogues of 
adenosine 4 and inosine:11 these have been incorpo-
rated into oligonucleotides and their duplex-forming 
properties investigated.12 With the objective of provid-
ing access to a wider range of pyridine-stretched pu-
rine derivatives, we have investigated the preparation 
of 9-substituted derivatives of the general types 5 and 
6 (R ≠ H) and now report the results of these studies. 
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Figure 1 
Two features of pyridine-stretched nucleosides may be 
advantageous: (i) the presence of the nitrogen atom in 
position 4 may enhance the stability of triplex-
forming oligonucleotides (TFOs) targeted to DNA; 
(ii) their preparation via addition-elimination reactions 
of 5-aminoimidazoles may make them more easily 
accessible than the benzene-stretched derivatives. The 
9-unsubstituted derivatives 2 and 4 were prepared via 
reaction of ethoxymethylene malononitrile [EMMN: 
(NC)2C=CHOEt] with the appropriate 5-
aminoimidazoles 8, which were obtained by reduction 
of the 5-nitroimidazoles 7.10,11 The preparation of the 
9-substituted derivatives 5 and 6 (R ≠ H) therefore 
requires a C-substituted analogue of EMMN that 
reacts selectively at the C-4 position of 5-
aminoimidazoles 8. 
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Figure 2 
In an earlier study,13,14 we showed that 5-
aminoimidazoles15 can react as either N- or C-
nucleophiles and demonstrated a correlation between 
the position of reaction and the softness of the elec-
trophile, measured by the AM1 calculated LUMO 
energy. Thus, EMMN [(NC)2C=CHOEt] (LUMO -
0.62 eV) gives exclusively C-adducts whereas diethyl 
ethoxymethylenemalonate [EMME: 
(EtO2C)2C=CHOEt] (LUMO -0.27 eV) gives exclu-
sively N-adducts. The general conclusion of our stu-
dies of a range of electrophiles was that reagents with 
a calculated (AM1) LUMO energy < 0.5 eV react 
predominantly at the C-4 position of 5-
aminoimidazoles.14 A C-substituted analogue of 
EMMN with a LUMO energy < 0.5 eV was therefore 
required in order to produce precursors of the 9-
substituted derivatives 5 and 6. Table 1 shows the 
AM1 calculated frontier orbital energies of selected 
electrophiles. 
From Table 1 it is clear that introduction of a second 
ethoxy substituent into EMME (Entries 2 and 4) will 
increase the LUMO energy and probably favour N-
adduct formation. However, replacement of the ethoxy 
group by a methylsulfanyl substituent (Entries 4 and 
7) significantly reduces the LUMO energy and intro-
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duction of a second methylsulfanyl group (Entry 8) 
leads to an electrophile with an exceptionally low 
energy LUMO. We therefore anticipated that 2-(bis-
methylsulfanylmethylene) malononitrile 9 
[(NC)2C=C(SMe)2] would give C-adducts with 5-
aminoimidazoles and thus provide access to 9-
methylsulfanyl derivatives that can be further manipu-
lated. Although we have not previously worked with 
the reagent 9, it is readily prepared in good yield by 
reaction of malononitrile with carbon disulfide and 
methyl iodide in the presence of potassium fluoride.16 
The LUMO energy lowering effect of an alkylsulfanyl 
substituent appears to be general: a similar effect is 
observed for the corresponding diesters (Entries 1 and 
3).    
 
Table 1 AM1 calculated frontier orbital energies of 
electrophiles 
Entry     Electrophile LUMO       
(eV) 
HOMO 
(eV) 
   1 (EtO2C)2C=CH.OEt -0.27 -10.15 
   2 (NC)2C=C(OEt)2 -0.29 -9.53 
   3 (EtO2C)2C=CH.SMe -0.60 -9.05 
   4 (NC)2C=CH.OEt -0.62 -10.05 
   5 (NC)2C=C(SMe)NHnPr -0.71 -8.93 
   6 (NC)2C=C(SMe)NHPh -0.90 -8.87 
   7 (NC)2C=CH.SMe -0.95 -9.11 
   8 (NC)2C=C(SMe)2 -1.31 -8.91 
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Scheme 1  
In these studies we have used 5-amino-1,2-
dimethylimidazole 12 as a model compound. A solu-
tion of the amine 12 in THF was generated by catalyt-
ic reduction (H2/Pd/C) of 1,2-dimethyl-5-
nitroimidazole 7 (R1 = R2 = Me). The amine solution 
was filtered through celite into a flask containing a 
five-fold excess of 2-(bis-methylsulfanylmethylene) 
malononitrile 9 and the mixture stirred at 50 oC over-
night. Workup gave a yellow-orange solid that was 
identified as the C-adduct 13. The yield based on ni-
toimidazole starting material was 47%. No other 
products were identified in the reaction mixture. An 
analytically pure sample (mp 197-8 oC) was prepared 
by flash chromatography and recrystallisation from 
EtOAc/MeOH. The structure 13 was fully supported 
by its spectroscopic properties. In particular the 1H 
NMR spectrum showed a broad singlet at d 7.05 cor-
responding to the NH2 group and the absence of an 
imidazole ring proton, which would be characteristic 
of the isomeric N-adduct. The constitution C10H11N5S 
was confirmed by mass spectrometry and elemental 
analysis.  
Treatment of a methanol solution of the C-adduct 13 
with aqueous NaOH at 60 oC resulted in cyclisation to 
the imidazo[4,5-b]pyridine 14 (mp 300 oC, 86%).  
Subsequent treatment with hot triethyl orthoformate 
gave the ethyl imidate 15 (mp 197-200 oC, 87%) 
which upon reaction with hot ethanolic ammonia gave 
the tricyclic amine 16 (mp 252-5 oC, 85%). The prop-
erties of the amine 16 were fully in accord with the 
proposed structure. The 1H NMR spectrum showed C-
Me, S-Me and N-Me singlets, at d 2.66, 2.94 and 3.75 
respectively, together with a broad NH2 signal (d 8.32) 
and a single ring proton (d 8.40). The mass spectrum 
showed a strong molecular ion (m/z 260). Compound 
16 is an example of a 9-substituted pyridine-stretched 
adenine derivative and the route shown in Scheme 1 
employing the soft bis-methylsulfanyl electrophile 9, 
therefore establishes a viable route to derivatives of 
this type. Treatment of compound 16 with hot 2M HCl 
(2 h) gave the pyridine-stretched hypoxanthine deriva-
tive 17 (mp >350 oC, 74%) which was fully characte-
rised. 
Reaction of the ethyl imidate 15 with n-propylamine 
under various conditions gave only the amidine 18 
and not the anticipated tricyclic N-n-propyl derivative 
19. All attempts at cyclisation were unsuccessful, 
although similar cyclisations of 9-unsubstituted deriv-
atives have been reported.15  
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Figure 3 
Inspection of Table 1 reveals that amino substituted 
electrophiles (Entries 5 and 6) also have a low energy 
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LUMO and might be expected to react selectively to 
give C-adducts. In principle these reagents could pro-
vide a direct route to 9-amino derivatives, e.g. 5 and 6 
(R3 = NHR). We therefore investigated the reactions 
of the reagents 10 and 11 with the aminoimidazole 12 
but in neither case was any reaction detected under a 
variety of conditions. As might be expected, the nitro-
gen lone pair appears to reduce the reactivity of the 
electrophile and although the LUMO energy is an 
indicator of regioselectivity it is not a measure of 
reactivity. To prepare 9-amino derivatives we next 
investigated methods of modifying the 9-
methylsulfanyl substituent.   
Reaction of compound 16 with n-propylamine did not 
result in substitution of the thiomethyl group by the 
amine. It was therefore decided to oxidize the thioeth-
er to the methyl sulfone which is a better leaving 
group. To avoid oxidation of the 8-amino group, N-
protected derivatives were prepared. Reaction with 
either acetic anhydride or acetic anhydride/ pyridine 
under various conditions gave the N,N-diacetyl de-
rivative 20 (mp 178-183 oC). In one experiment a very 
low yield of material (mp 218-220 oC) that appeared 
to be the mono-acetyl derivative was obtained but 
attempts to repeat this by variation of method or 
work-up were unsuccessful. Attempts to remove one 
acetyl group using calcium carbonate in MeOH/H2O99 
resulted in removal of both acetyl groups. We there-
fore decided to carry out further work on the diacetyl 
derivative 20. The 8-amino group was also protected 
as the t-butoxycarbonyl (t-Boc) derivative 21 (mp 167 
oC (d): 83%) by reaction with di-t-butyl dicarbonate in 
1,4-dioxane (6 h at 120 oC).  
Oxidation of the N,N-diacetyl derivative 20 with one 
equivalent of 3-chloroperoxybenzoic acid (MCPBA) 
in CH2Cl2 at 0 oC gave a poor yield (11%) of the sul-
foxide 22. A similar procedure gave a better yield 
(63%) of the sulfoxide 23. Both sulfoxides were fully 
characterized and showed the expected spectroscopic 
properties. Oxidation using two equivalents of 
MCPBA gave the sulfones 24 (mp 185-6 oC, 67%) 
and 25 (mp 100 oC (d), 65%), respectively. Further 
studies were carried out using the t-Boc protected 
sulfone 25, which was obtained in greater overall 
yield from the amine 16. 
To demonstrate nucleophilic substitution of the methyl 
sulfonyl substituent we initially reacted compound 25 
with sodium ethoxide in ethanol at room temperature. 
A single product was formed and, after chromato-
graphic isolation in 24% yield, was identified as the 9-
ethoxy derivative (mp 204 oC (d)). 1H NMR spectros-
copy clearly showed the product contained an ethyl 
substituent (d 1.67 and 5.34) and the absence of a 
methyl sulfone signal (d ~3.9). Excellent yields of 
substitution products were obtained, without chroma-
tography, when the sulfone 25 was reacted with alky-
lamines. With n-propylamine in CH2Cl2 at room tem-
perature (2 h) a 98% yield of the secondary amine 27 
(mp 218 oC(d)) was obtained. A similar procedure 
gave the n-butyl derivative 28 (mp 220 oC (d)) in 93% 
yield. The use of 9-sulfones, e.g. 25, therefore pro-
vides access to 8,9-diamino derivatives in the pyri-
dine-stretched purine series. 
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Scheme 2 
The application of this methodology to the synthesis 
of 2’-deoxyribonucleotide analogues requires the 
reaction of 2-(bis-methylsulfanylmethylene) malono-
nitrile 9 with 5-aminoimidazole 29 to give the C-
adduct 30. We have therefore made a preliminary 
investigation: reaction of the amine 2911 with electro-
phile 9 gave a single product which after chromato-
graphy was identified as the desired adduct 30 (mp 
98-100 oC, 15%), which was fully characterized. The 
yield was low and requires optimization but the regi-
oselectivity of the reaction demonstrates that this is a 
potential route to 9-substituted derivatives. 
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IR spectra were obtained using a Thermo-Nicolet 
Avatar 370 Fourier Transform Infra Red spectrometer. 
Mass spectra were obtained at the EPSRC National 
Mass Spectrometry Centre, University of Wales 
Swansea and were either low resolution electron im-
pact (EI/LR), low resolution electrospray (ES/LR) or 
high resolution electrospray (ES/HR). Melting points 
were measured on a Stuart Scientific SMP3 melting 
point apparatus. NMR spectra were recorded on a 
Bruker Advance DPX300 NMR spectrometer in 
CDCl3 or d6-DMSO. Chemical shifts are quoted as 
ppm relative to TMS as internal standard. Solvents 
were dried as follows: THF was heated under reflux 
over, and then distilled from, sodium wire and benzo-
phenone; DMF was dried by distillation, and then 
standing, over 4Å molecular sieves; pyridine was 
refluxed over KOH and allowed to stand over 4Å 
molecular sieves; 1,4-dioxane was refluxed over so-
dium and benzophenone, distilled off and stored over 
molecular sieves under a nitrogen atmosphere. TLC 
was carried out on aluminium backed 0.2mm silica 
gel and visualised with 254nm fluorescent indicator. 
Microanalyses were conducted through the Elemental 
Analysis Service at London Metropolitan University. 
AM1 calculations17 were performed using the MO-
PAC programme in CS Chem3D (CambridgeSoft 
Corporation). Calculated frontier orbital energies vary 
with configuration but variations in the values record-
ed in Table 1 do not change the conclusions.  
2-(Bis-methylsulfanylmethylene)malononitrile 916 and 
2-(methylsulfanyl-phenylaminomethylene) malononi-
trile 1118 were prepared by literature methods. 
2-(Methlysulfanyl-propylaminomethylene)-
malononitrile 10 
2-(Bis-methylsulfanylmethylene)malononitrile 9 (4.00 
g, 23.5 mmol) was dissolved in ethanol (25 mL) with 
stirring. n-Propylamine (1 mL, 11.8 mmol) was added 
dropwise over one hour and the mixture left to stir 
overnight. The solvent was then removed under re-
duced pressure and the solid product purified by col-
umn chromatography eluting with CH2Cl2 to remove 
the starting material followed by 5% MeOH in 
CH2Cl2 to give the product 10 (1.66 g, 78%); pale 
pink solid; mp 119-122 oC. 
IR (KBr): 632, 864, 920, 1153, 1248, 1290, 1302, 
1364, 1419, 1442, 1467, 1500, 1548, 2187, 2206, 
2877, 2935, 2964, 3306 cm-1. 
1H NMR (CDCl3): d = 0.99 (t, J = 7.0 Hz, 3H, 
NHCH2CH2CH3), 1.67 (sextet, J = 7.0 Hz, 2H, 
NHCH2CH2CH3), 2.68 (s, 3H, SCH3), 3.53 (q, J = 7.0 
Hz, 2H, NHCH2CH2CH3), 6.31 (br s, 1H, NH).  
13C NMR (CDCl3): d = 11.00 (NHCH2CH2CH3), 
17.55 (SCH3), 23.31 (NHCH2CH2CH3), 48.33 
(NHCH2CH2CH3), 52.22 (C(CN)2), 115.35 (CN), 
115.64 (CN), 174.69 (C=C(CN)2). 
MS (EI/LR): m/z (%) = 181 (38) [M+], 166 (9), 152 
(18), 140 (13), 127 (15), 109 (12), 108 (19), 92 (58), 
79 (15), 74 (22), 68 (22), 61 (63), 48 (25), 47 (33), 45 
(40), 43 (75), 41 (100). 
Anal. Calcd for C8H11N3S (181.26): C, 53.01; H 6.12; 
N 23.18. 
Found: C, 52.93; H, 6.17; N, 23.05. 
2-[(5-Amino-1,2-dimethyl-1H-imidazol-4-yl)-
methylsulfanyl-methylene]malononitrile 13 
1,2-Dimethyl-5-nitroimidazole 7 (R1 =  R2 = Me) 
(1.58 g, 11.2 mmol) and 5% Pd/C catalyst (1.20 g) 
were placed in a flask with dry THF (125 mL). The 
resulting mixture was hydrogenated at rt and atmos-
pheric pressure, with vigorous stirring, over two 
hours. The reaction was monitored by TLC (Et2O) and 
showed the consumption of all starting material. The 
product mixture was filtered through dry celite, in an 
enclosed system under argon, into a flask containing 
2-(bis-methylsulfanylmethylene) malononitrile 9 (9.64 
g, 56.5 mmol). The reaction was stirred at 50 oC, un-
der argon, overnight giving an orange-brown solution.   
The solvent was removed under reduced pressure at rt 
and the residue treated with liquid nitrogen-chilled 
EtOAc (100 mL). The solution was then filtered to 
give a yellow-orange solid. The crude product 13 was 
used without further purification (yield over two stag-
es 47%). 
    An analytical sample was prepared by dissolving 
the solid in a minimum amount of MeOH followed by 
flash column chromatography (EtOAc as eluent). The 
relevant fractions were combined and the solvent 
removed by rotary evaporation giving a yellow solid 
that was recrystallised (EtOAc: MeOH 5:3) to give the 
product 13 (0.70 g, 27%); brilliant yellow crystals; mp 
197-198 oC.    
IR (KBr): 1313, 1489, 1603, 2213, 2251, 3469 cm-1. 
1H NMR (d6-DMSO): d = 2.23 (s, 3H, S-CH3), 2.49 
(s, 3H, C-CH3), 3.34 (s, 3H, N-CH3), 7.05  (br s, 2H, 
NH2).  
13C NMR (d6-DMSO): d = 13.22 (C-CH3), 17.81 (S-
CH3), 29.38 (N-CH3), 60.64 (methylene-C1), 113.70 
(imidazole-C5), 116.85 (CN), 143.52 (imidazole-C4), 
147.64 (imidazole-C2), 164.26 (methylene-C2). 
MS (EI/LR): m/z (%) = 233 (100) [M+], 218 (8), 200 
(22), 187 (21), 161 (17), 123 (4), 104 (10), 84 (22), 56 
(63), 49 (29), 42 (24). 
Anal. Calcd for C10H11N5S (233.29): C, 51.48; H, 
4.75; N, 30.02%. 
Found: C, 51.53; H, 4.86; N, 29.84%. 
 
5-Amino-2,3-dimethyl-7-methylsulfanyl-3H-
imidazo[4,5-b]pyridine-6-carbonitrile 14 
2-[(5-Amino-1,2-dimethyl-1H-imidazol-4-yl)-
methylsulfanyl-methylene]malononitrile 13 (0.20 g, 
0.86 mmol) was placed in a flask with MeOH (50 mL) 
and heated to 60 oC. NaOH (0.18 g) in H2O (2 mL) 
was added to the reaction mixture.   The reaction was 
followed by TLC (EtOAc: MeOH 10:1) and after 20 
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min. showed one fluorescent spot (rf 0.67). The mix-
ture was cooled to rt and the precipitate collected, 
recrystallised from DMF and identified as the product 
14 (0.17 g, 86%); off-white crystals; mp 300 oC.    
IR (KBr): 517, 639, 899, 1370, 1425, 1488, 1560, 
1585, 1648, 2202, 2931, 3338, 3412 cm-1.  
1H NMR (d6-DMSO): d = 2.45 (s, 3H, C-CH3), 3.03 
(s, 3H, S-CH3), 3.54 (s, 3H, N-CH3), 6.54 (br s, 2H, 
NH2).  
13C NMR (d6-DMSO): d = 14.38 (C-CH3), 16.74 (S-
CH3), 28.64 (N-CH3), 83.63 (C6), 117.20 (CN), 
126.01 (C1a), 144.52 (C3a), 149.82 (C2), 151.59 
(C7), 157.94 (C5). 
MS (EI/LR): m/z (%) = 233 (100) [M+], 232 (24), 218 
(9), 206 (11), 200 (25), 188 (12), 187 (27), 186 (15), 
145 (13), 123 (12), 117 (12), 109 (18), 105 (23), 104 
(44), 95 (21), 91 (45), 82 (44), 77 (56), 69 (34), 67 
(43). 
Anal. Calcd for C10H11N5S (233.29):  C, 51.48; H, 
4.75; N, 30.02. 
Found: C, 51.33; H, 4.67; N, 29.90. 
 
N-(6-Cyano-2,3-dimethyl-7-methylsulfanyl-3H-
imidazo[4,5-b]pyridin-5-yl)-formimidic acid ethyl 
ester 15 
5-Amino-2,3-dimethyl-7-methylsulfanyl-3H-
imidazo[4,5-b]pyridine-6-carbonitrile 14 (5.96 g, 25.5 
mmol), triethyl orthoformate (500 mL) and para-
toluenesulphonic acid monohydrate (0.81 g, 4.3 
mmol) were placed in a flask fitted with a Claisen 
head and condenser. The mixture was heated to 150 
oC (4 h).   Activated carbon was then added and the 
hot mixture filtered. The precipitate, which appeared 
on cooling, was collected and washed with a little 
Et2O giving the product 15 (6.43 g, 87%); fine colour-
less crystals; mp 197-200 oC.    
IR (KBr): 1196, 1226, 1559, 1580, 1627, 2214,  2935 
cm-1. 
1H NMR (d6-DMSO): d = 1.36 (t, J = 7.0 Hz, 3H, 
CH3CH2), 2.56 (s, 3H, C-CH3), 3.11 (s, 3H, S-CH3), 
3.69 (s, 3H, N-CH3), 4.37 (q, J = 7.0 Hz, 2H, 
CH3CH2), 8.56 (s, 1H, CH-OEt).  
13C NMR (d6-DMSO): d = 13.84 (C-CH3), 13.98 
(CH3CH2), 16.28 (S-CH3), 28.35 (N-CH3), 63.34 
(CH3CH2), 94.81 (C6), 115.78 (CN), 130.10 (C1a),  
144.19 (C3a), 147.75 (C2), 153.98 (C7), 156.10 
(EtOC=N), 160.45 (C5). 
MS (EI): m/z (%) = 289 (21) [M+], 260 (100), 244 
(46), 232 (15), 186 (12), 171 (10), 145 (12), 135 (12), 
104 (19), 91 (15), 77 (13), 56 (57), 46 (12), 42 (18). 
Anal. Calcd for C13H15N5OS (289.36): C, 53.92; H, 
5.22; N, 24.29. 
Found: C, 53.75; H, 5.00; N, 24.07. 
 
2,3-Dimethyl-9-methylsulfanyl-3H-1,3,4,5,7-
pentaaza-cyclopenta [b]naphthalen-8-ylamine 16 
N-(6-Cyano-2,3-dimethyl-7-methylsulfanyl-3H-
imidazo[4,5-b]pyridin-5-yl)-formimidic acid ethyl 
ester 15 (3.03 g, 10.5 mmol) was added to EtOH (300 
mL) saturated with ammonia. The mixture was stirred 
at rt (1 h) and then heated under reflux overnight. The 
mixture was cooled in a freezer and the precipitate 
collected and identified as the product 16 (2.31 g, 
85%); fine colourless crystals; mp 252-255 oC.   An 
analytical sample was recrystallised from iso-
propanol. 
IR (KBr): 1346, 1401, 1429, 1455, 1500, 1521, 1551, 
1576, 1638, 2360, 2937, 3075, 3282, 3434 cm-1. 
1H NMR (d6-DMSO): d = 2.66 (s, 3H, C-CH3), 2.94 
(s, 3H, S-CH3), 3.75 (s, 3H, N-CH3), 8.32 (br s, 2H, 
NH2), 8.40 (s, 1H, CH).  
13C NMR (d6-DMSO): d = 14.45 (C-CH3), 19.48 (S-
CH3), 28.27 (N-CH3), 105.43 (C8a), 133.47 (C1a), 
135.41 (C3a), 150.56 (C9), 155.78 (C2), 155.90 (C6), 
157.88 (C4a), 163.70 (C8). 
MS (EI): m/z (%) = 260 (88) [M+], 254 (13), 245 (21), 
234 (12), 233 (53), 227 (75), 218 (16), 214 (22), 212 
(44), 210 (68), 204 (71), 197 (100), 187 (85), 179 
(59), 169 (62). 
Anal. Calcd for C11H12N6S (260.32): C, 50.75; H, 
4.65; N, 32.28. 
Found: C, 50.60; H, 4.44; N, 32.28. 
 
2,3-Dimethyl-9-methylsulfanyl-3,7-dihydro-
1,3,4,5,7-pentaaza-cyclopenta[b]naphthalen-8-one 
17 
2,3-Dimethyl-9-methylsulfanyl-3H-1,3,4,5,7-
pentaaza-cyclopenta[b]naphthalen-8-ylamine 16 (1.00 
g, 3.8 mmol) in 2M HCl (100 mL) was heated under 
reflux (2 h). The solution was cooled in an ice bath 
and basified with aqueous ammonia. The resulting 
precipitate was collected, washed with H2O, EtOH 
and finally Et2O giving the product 17 (0.74 g, 74%); 
colourless solid; mp >350 oC. 
IR (KBr): 956, 1242, 1314, 1324, 1351, 1373, 1423, 
1472, 1548, 1575, 1615, 1668, 2629, 2910, 3046 cm-1. 
1H NMR (TFA): d = 3.12 (s, 3H, C-CH3), 3.15 (s, 3H, 
S-CH3), 4.17 (s, 3H, N-CH3), 9.56 (s, 1H, CH).  
13C NMR (TFA): d = 14.74 (C-CH3), 20.18 (S-CH3), 
33.08 (N-CH3), 126.42 (C8a), 149.03 (C1a), 151.31 
(C3a), 154.42 (C9), 155.07 (C2), 161.66 (C6), 161.99 
(C4a), 166.41 (C8). 
MS (EI): m/z (%) = 261 (31) [M+], 228 (15), 187 (9), 
105 (10), 91 (17), 77 (9), 56 (12), 44 (100). 
Anal. Calcd forC11H11N5SO (261.30): C, 50.56; H, 
4.24; N, 26.80. 
Found: C, 50.54; H, 4.06; N, 26.65. 
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N-(6-Cyano-2,3-dimethyl-7-methylsulfanyl-3H-
imidazo[4,5-b]pyridin-5-yl)-N’-propyl-
formamidine 18 
 
N-(6-cyano-2,3-dimethyl-7-methylsulfanyl-3H-
imidazo[4,5-b]pyridin-5-yl)-formimidic acid ethyl 
ester 15 (0.50 g, 1.7 mmol) and n-propylamine (0.70 
mL, 8.5 mmol) in EtOH (25 mL) were allowed to 
stand at rt (18 h).   The solvent and excess amine were 
removed under reduced pressure. The solid residue 
was recrystallised (EtOAc and petroleum ether) and 
identified as the product 18 (0.31 g, 58%); off-white 
crystals; mp 147-149 oC. 
IR (KBr):  938, 959, 1151, 1195, 1250, 1349, 1373, 
1423, 1475, 1574, 1615, 2212, 2873, 2929, 2958, 
3243 cm-1. 
1H NMR (d6-DMSO): d = 0.97 (t, J = 7.5 Hz, 3H, 
NHCH2CH2CH3), 1.64 (m, 2H, NHCH2CH2CH3), 
3.05 (s, 3H, C-CH3), 3.34 (s, 3H, S-CH3), 3.38 (q, J = 
6.5 Hz, 2H, NHCH2CH2CH3), 3.62 (s, 3H, N-CH3), 
8.09 (d, J = 4.5 Hz, 1H, CH), 8.52 (d, J = 4.5 Hz, 1H, 
NH).  
13C NMR (d6-DMSO): d = 11.44 (NHCH2CH2CH3), 
13.89 (C-CH3), 16.17 (S-CH3), 21.49 
(NHCH2CH2CH3), 28.07 (N-CH3), 42.16 
(NHCH2CH2CH3), 94.16 (C6), 116.89 (CN), 128.27 
(C1a), 143.56 (C3a), 148.16 (C2), 152.30 (C7), 
153.21 (N=C-N), 160.11 (C5).  
MS (EI): m/z (%) = 302 (26) [M+], 287 (10), 269 (12), 
244 (9), 200 (13), 187 (22), 56 (14). 
Anal. Calcd for C14H18N6S (302.4): C, 55.61; H, 6.00; 
N, 27.79. 
Found: C, 55.64; H, 5.79; N, 27.61. 
 
N-Acetyl-N-(2,3-dimethyl-9-methylsulfanyl-3H-
1,3,4,5,7-pentaaza-cyclopenta[b]naphthalen-8-yl)-
acetamide 20 
To a suspension of 2,3-dimethyl-9-methylsulfanyl-3H-
1,3,4,5,7-pentaaza-cyclopenta[b]naphthalen-8-
ylamine 16 (2.00 g, 7.7 mmol) in pyridine (27 mL) 
was added Ac2O (20 mL). The mixture was heated 
under reflux (2 h) and then poured onto ice water (50 
mL). The product was extracted into CH2Cl2 (2 x 
50mL), dried (MgSO4) and the solvent reduced by 
half (~20 mL).   Et2O was added and the solution left 
to cool overnight. The precipitate was collected, dried 
under high vacuum at 100 oC and identified as the 
product 20 (2.01 g, 76% yield); fine yellow crystals; 
mp 178-183 oC. 
IR (KBr):  1163, 1219, 1296, 1353, 1404, 1479, 1539, 
1574, 1608, 1731, 2341, 2359, 2930, 3007 cm-1.  
1H NMR (CDCl3): d = 2.30 (s, 6H, NC(O)CH3), 2.66 
(s, 3H, C-CH3), 3.17 (s, 3H, S-CH3), 3.86 (s, 3H, N-
CH3), 9.29 (s, 1H, CH).  
13C NMR (CDCl3): d = 15.01 (C-CH3), 20.11 (S-
CH3), 27.10 (NC(O)CH3) 28.93 (N-CH3), 115.15 
(C8a),  136.06 (C1a), 138.28 (C3a),  152.94 (C9), 
155.70 (C2),  157.79 (C6), 157.85 (C4a), 160.60 (C8), 
171.67 (NC(O)CH3). 
MS (EI): m/z (%) = 344 (3) [M+], 301 (3), 269 (12), 
255 (19), 245 (12), 227 (3), 171 (6), 135 (2), 94 (6), 
82 (3), 56 (12), 43 (100). 
Anal. Calcd for C15H16N6O2S (344.39): C, 52.31; H, 
4.68; N, 24.40. 
Found: C, 52.43; H, 4.36; N, 24.19. 
 
(2,3-Dimethyl-9-methanesulfanyl-3H-1,3,4,5,7-
pentaaza-cyclopenta[b]naphthalen-8-yl)-carbamic 
acid tert-butyl ester 21 
2,3-Dimethyl-9-methylsulfanyl-3H-1,3,4,5,7-
pentaaza-cyclopenta[b]naphthalen-8-ylamine 16 (1.00 
g, 3.8 mmol) was suspended in dry 1,4-dioxane (100 
mL) and heated to 120 oC. When all the starting ma-
terial had dissolved, di-tert-butyl dicarbonate (4.19 g, 
19.2 mmol) was added and the solution stirred (5 h) 
after which TLC (MeOH) showed that all starting 
material had reacted. The solvent was removed by 
evaporation and the resulting solid treated with Et2O 
(50 mL). The solid was then collected, washed with 
further Et2O (2 x 25 mL) and identified as the product 
21 (1.15 g, 83% yield); yellow solid; mp 167 oC (de-
comp.). 
IR (KBr): 1060, 1152, 1248, 1305, 1353, 1372, 1426, 
1505, 1580, 1697, 1758, 2923, 2976, 3422 cm-1. 
1H NMR (CDCl3): d = 1.61 (s, 9H, C(CH3)3), 2.77 (s, 
3H, C-CH3), 2.87 (s, 3H, S-CH3), 3.91 (s, 3H, N-
CH3), 9.10 (s, 1H, CH), 11.49 (br s, 1H, NH). 
13C NMR (CDCl3): d = 15.08 (C-CH3), 20.74 (S-
CH3), 28.25 (O-(CH3)3), 28.97 (N-CH3), 82.21 
((Me)3-C-O), 108.08 (C8a), 131.27 (C1a), 138.25 
(C3a), 149.79 (C9), 151.74 (HN-COO), 156.09 (C2), 
156.46 (C6), 158.64 (C4a), 159.72 (C8). 
Anal. Calcd for C16H20N6O2S (360.44): C, 53.32; H, 
5.59; N, 23.32. 
Found: C, 53.03; H, 5.43; N, 23.57. 
 
N-Acetyl-N-(9-methanesulfinyl-2,3-dimethyl-3H-
1,3,4,5,7-pentaaza-cyclopenta[b]naphthalen-8-yl)-
acetamide 22 
N-Acetyl-N-(2,3-dimethyl-9-methylsulfanyl-3H-
1,3,4,5,7-pentaaza-cyclopenta[b]naphthalen-8-yl)-
acetamide 20 (194 mg, 0.56 mmol) was dissolved in 
CH2Cl2 (20 mL) and cooled to 0 oC. 3-
Chloroperoxybenzoic acid (50-55%)(194 mg, 0.56 
mmol) was added and the mixture stirred (1.5 h). The 
organic layer was then washed with sat. aq NaHCO3 
(2 x 20 mL) and H2O (2 x 20 mL). The organic layer 
was then dried (MgSO4) and the solvent removed 
under reduced pressure.   The crude material was dis-
solved in EtOAc and the solvent reduced until crystal-
lisation began. After cooling, the solid was collected 
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and identified as the product 22 (22 mg, 11% yield); 
yellow crystals; mp 191-192 oC. 
IR (KBr): 568, 599, 640, 685, 926, 867, 1006, 1040, 
1067, 1157, 1230, 1301, 1369, 1423, 1475, 1514, 
1577, 1616, 1698, 1720, 2922, 3006 cm-1. 
1H NMR (CDCl3): d = 2.12 (s, 3H, CO-CH3), 2.65 s, 
(3H, CO-CH3), 2.88 (s, 3H, C-CH3), 3.45 (s, 3H, SO-
CH3), 4.01 (s, 3H, N-CH3), 9.46 (s, 1H, CH).  
13C NMR (CDCl3): d = 15.97 (C-CH3), 26.76 
(NC(O)CH3), 28.15 (NC(O)CH3), 29.69 (N-CH3), 
40.86 (SO-CH3), 113.77 (C8a), 136.33 (C3a), 138.37 
(C1a), 156.00 (C9), 156.36 (C2), 156.82 (C6),  160.42 
(C4a), 164.18 (C8), 170.72 (NC(O)CH3), 174.51 
(NC(O)CH3). 
MS (EI): m/z (%) = 361 (3) [M+H+], 345 (9), 303 (6), 
277 (4), 255 (85), 246 (6), 200 (6), 120 (26), 119 (54), 
111 (8), 97 (12), 77 (100). 
Anal. Calcd for C15H16N6O3S (360.39): C, 49.99; H, 
4.47; N, 23.32. 
Found: C, 49.73; H, 4.52; N, 23.06. 
 
(9-Methanesulfinyl-2,3-dimethyl-3H-1,3,4,5,7-
pentaaza-cyclopenta[b]naphthalen-8-yl)-carbamic 
acid tert-butyl ester 23 
Using the procedure described for compound 22, 
compound 23 was obtained from (2,3-dimethyl-9-
methanesulfanyl-3H-1,3,4,5,7-pentaaza-
cyclopenta[b]naphthalen-8-yl)-carbamic acid tert-
butyl ester 21 (1.00 g, 2.8 mmol); yield: 0.66 g, 63%; 
pale yellow, crystalline solid; mp 172 oC (decomp.). 
IR (KBr): 749, 812, 839, 879, 927, 958, 1022, 1074, 
1146, 1225, 1252, 1307, 1373, 1429, 1493, 1527, 
1588, 1752, 2728, 2927, 2978, 3494 cm-1. 
1H NMR (CDCl3): d = 1.59 (s, 9H, C(CH3)3), 2.79 (s, 
3H, C-CH3), 3.12 (s, 3H, SO-CH3), 3.95 (s, 3H, N-
CH3), 9.22 (s, 1H, CH), 12.28 (br s, 1H, NH). 
13C NMR (CDCl3): d = 15.56 (C-CH3), 28.66 (O-
C(CH3)3), 29.57 (N-CH3), 39.84 (SO-CH3), 82.18 
((Me)3-C-O), 107.99 (C8a), 134.44 (C3a), 136.30 
(C1a), 151.54 (C2), 153.33 (HN-COO), 157.30 (C9), 
158.27 (C6), 158.81 (C4a), 162.37 (C8). 
 
N-Acetyl-N-(9-methanesulfonyl-2,3-dimethyl-3H-
1,3,4,5,7-pentaaza-cyclopenta[b]naphthalen-8-yl)-
acetamide 24 
 
N-Acetyl-N-(2,3-dimethyl-9-methylsulfanyl-3H-
1,3,4,5,7-pentaaza-cyclopenta[b]naphthalen-8-yl)-
acetamide 20 (2.00 g, 5.8 mmol) was dissolved in 
CH2Cl2 (50 mL) and cooled to 0 oC. 3-
Chloroperoxybenzoic acid (50-55%) (4.00 g, 11.6 
mmol) was added and the mixture stirred (4 h). The 
organic layer was diluted with a further portion of 
CH2Cl2 (50 mL), washed with H2O (2 x 100 mL) and 
dried (MgSO4). After the solvent had been removed 
under reduced pressure, the crude solid was recrystal-
lised from EtOAc and identified as the product 24 
(1.51 g, 67%); orange crystals; mp 185-186 oC. 
IR (KBr): 537, 579, 640, 755, 933, 1009, 1038, 1122, 
1152, 1211, 1236, 1259, 1310, 1353, 1366, 1404, 
1426, 1485, 1517, 1561, 1577, 1623, 1706, 1733, 
2924, 3016 cm-1. 
1H NMR (CDCl3): d = 2.48 (s, 6H, CO-CH3), 2.81 (s, 
3H, C-CH3), 3.83 (s, 3H, SO2-CH3), 3.98 (s, 3H, N-
CH3), 9.42 (s, 1H, CH).  
13C NMR (CDCl3): d = 15.44 (C-CH3), 27.89 
(C(O)CH3), 29.36 (N-CH3), 48.90 (S-CH3), 112.17 
(C8a),  132.79 (C3a), 132.83 (C1a), 143.21 (C2), 
155.55 (C9),  155.86 (C6), 160.25 (C4a), 163.78 (C8), 
173.18 (C(O)CH3). 
MS (EI): m/z (%) = 377 (2%) [M+H+], 299 (4), 255 
(35), 215 (4), 200 (7), 177 (4), 163 (4), 140 (4), 119 
(9), 111 (18), 97 (24), 77 (100), 60 (12). 
Anal. Calcd for C15H16N6O4S (376.39): C, 49.87; H, 
4.28; N, 22.33. 
Found: C, 47.69; H, 4.05; N, 22.11. 
 
(9-Methanesulfonyl-2,3-dimethyl-3H-1,3,4,5,7-
pentaaza-cyclopenta[b]naphthalen-8-yl)carbamic 
acid tert-butyl ester 25 
Using the procedure described for compound 24, 
compound 25 was obtained from (2,3-dimethyl-9-
methanesulfanyl-3H-1,3,4,5,7-pentaaza-
cyclopenta[b]naphthalen-8-yl)-carbamic acid tert-
butyl ester 21 (2.00 g, 5.5 mmol); yield: 1.42 g, 65%; 
dark gold, crystalline solid; mp 100 oC (decomp.). 
IR (KBr): 774, 840, 1145, 1218, 1245, 1297, 1353, 
1375, 1414, 1509, 1578, 1752, 2925, 2976, 3422 cm-1. 
1H NMR (CDCl3): d = 1.59 (s, 9H, C(CH3)3), 2.79 (s, 
3H, C-CH3), 3.92 (s, 3H, SO2-CH3), 3.95 (s, 3H, N-
CH3), 9.16 (s, 1H, CH), 10.03 (br s, 1H, NH). 
13C NMR (CDCl3): d = 15.69 (C-CH3), 28.53 (O-
C(CH3)3), 29.56 (N-CH3), 48.26(SO2-CH3), 82.44 
((Me)3-C-O), 104.32 (C8a), 132.17 (C3a), 133.95 
(C1a), 150.91 (HN-COO), 154.93 (C2), 155.97 (C9), 
156.83 (C6), 157.16 (C4a), 163.16 (C8). 
 
(9-Ethoxy-2,3-dimethyl-3H-1,3,4,5,7-pentaaza-
cyclopenta[b]naphthalen-8-yl)-carbamic acid tert-
butyl ester 26 
 (9-Methanesulfonyl-2,3-dimethyl-3H-1,3,4,5,7-
pentaaza-cyclopenta[b]naphthalen-8-yl)-carbamic acid 
tert-butyl ester 25 (0.50 g, 1.3 mmol) was dissolved in 
EtOH (50 mL) with stirring.   Sodium metal (0.10 g, 
2.5 mmol) was then added and the mixture stirred for 
30 min. at which point TLC (EtOAc: MeOH 5:1) 
showed the disappearance of the starting material and 
a new slower running spot (rf: 0.38).  The EtOH was 
removed under reduced pressure and the residue re-
dissolved in CH2Cl2 (50 mL). The organic layer was 
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then washed with H2O (2 x 50 mL), dried (MgSO4) 
and the solvent removed.The solid product was then 
purified by column chromatography (3:1 
EtOAc:MeOH) and the relevant fractions combined to 
give compound 26 (0.11 g, 24%); colourless solid; 
mp: 204 oC (decomp.). 
IR (KBr): 815, 949, 1016, 1060, 1109, 1143, 1241, 
1356, 1369, 1380, 1466, 1507, 1555, 1597, 1624, 
1663, 1751, 2973, 3342 cm-1. 
1H NMR (CDCl3): d = 1.58 (s, 9H, C(CH3)3), 1.67 (t, 
J = 7.0 Hz, 3H, OCH2CH3) 2.65 (s, 3H, C-CH3), 3.86 
(s, 3H, N-CH3), 5.34 (q, J = 7.0 Hz, 2H, OCH2CH3),  
9.01 (s, 1H, CH), 10.40 (br s, 1H, NH). 
13C NMR (CDCl3): d = 15.02 (O-CH2CH3), 15.75 (C-
CH3), 28.54 (O-C(CH3)3), 29.26 (N-CH3), 72.23 (O-
CH2CH3), 82.10 ((CH3)3-C-O), 100.20 (C8a), 122.51 
(C1a), 149.85 (C3a), 152.39 (HN-COO), 155.45 (C2), 
155.63 (C6), 157.21 (C4a), 157.42 (C8), 158.92 (C9). 
MS (EI): m/z (%) = 359 (14) [M+H+], 259 (100), 244 
(24), 222 (67), 204 (24), 192 (22), 176 (22), 150 (30), 
148 (42), 135 (53), 122 (71), 100 (64), 98 (76), 84 
(76), 72 (86). 
HRMS(ES): m/z calcd for C17H22N6O3 [M+H+]: 
359.1826; found: 359.1825. 
 
(2,3-Dimethyl-9-propylamino-3H-1,3,4,5,7-
pentaaza-cyclopenta[b]naphthalen-8-yl) carbamic 
acid tert-butyl ester 27 
(9-Methanesulfonyl-2,3-dimethyl-3H-1,3,4,5,7-
pentaaza-cyclopenta[b]naphthalen-8-yl)-carbamic acid 
tert-butyl ester 25 (0.86 g, 2.2 mmol) was dissolved in 
CH2Cl2 (75 mL). To this solution was added n-
propylamine (0.18 mL, 2.2 mmol) and stirring was 
maintained at rt (2 h). The solvent was removed under 
reduced pressure and the resulting solid dried under 
high vacuum at 70 oC (12 h) to give the product 20 
(0.80 g, 98%); dark yellow solid; mp 218 oC (de-
comp.). 
IR (KBr): 1003, 1071, 1114, 1157, 1218, 1253, 1384, 
1439, 1528, 1586, 1652, 1700, 2862, 2965, 3408 cm-1. 
1H NMR (CDCl3): d = 1.15 (t, J = 7.0 Hz, 3H, 
NHCH2CH2CH3), 1.53 (s, C(CH3)3), 1.77 (m, 2H, 
NHCH2CH2CH3), 2.55 (s, 3H, C-CH3), 3.74 (s, 3H, 
N-CH3), 4.18 (q, J = 6.0 Hz, 2H, NHCH2CH2CH3), 
8.05 (s, 1H, CH), 11.63 (t, J = 6.0 Hz, 1H, 
NHCH2CH2CH3), 13.60 (br s, 1H, Boc-NH). 
13C NMR (CDCl3): d = 11.82 (NHCH2CH2CH3), 14.7 
(C-CH3), 23.49 (NHCH2CH2CH3), 28.57 (O-
C(CH3)3), 29.00 (N-CH3), 47.57 (NHCH2CH2CH3), 
80.24 ((CH3)3-C-O), 98.04 (C8a), 120.13 (C1a), 
142.97 (C3a), 148.94 (C2), 149.19 (C9), 151.78 
(C4a), 156.50 (C6), 160.73 (HNCOO), 163.65 (C8). 
 
(9-Butylamino-2,3-dimethyl-3H-1,3,4,5,7-pentaaza-
cyclopenta[b]naphthalen-8-yl)- carbamic acid tert-
butyl ester 28 
Using the procedure described for compound 27, 
compound 28 was obtained from (9-methanesulfonyl-
2,3-dimethyl-3H-1,3,4,5,7-pentaaza-
cyclopenta[b]naphthalen-8-yl)-carbamic acid tert-
butyl ester 25 (1.00 g, 2.6 mmol); yield: 0.91 g 93%; 
dark orange solid;  mp 220 oC (decomp.). 
IR (KBr): 1041, 1157, 1264, 1367, 1585, 1700, 1718, 
1621, 1646, 2867, 2924, 2964, 3439 cm-1. 
1H NMR (CDCl3): d = 0.99 (t, J = 7.0 Hz, 3H, 
NHCH2CH2CH2CH3), 1.52 (s, 9H, C(CH3)3), 1.62-
1.76 (m, 4H, NHCH2CH2CH2CH3 and 
NHCH2CH2CH2CH3), 2.54 (s, 3H, C-CH3), 3.72 (s, 
3H, N-CH3), 4.21 (q, J = 6.0 Hz, 2H, 
NHCH2CH2CH2CH3), 8.04 (s, 1H, CH), 11.58 (br s, 
1H, NHCH2CH2CH2CH3), 13.62 (br s, 1H, Boc-NH). 
13C NMR (CDCl3): d = 14.40 (NHCH2CH2CH2CH3), 
14.68 (C-CH3), 20.29 (NHCH2CH2CH2CH3), 28.60 
(O-C(CH3)3), 29.00 (N-CH3), 32.28 
(NHCH2CH2CH2CH3) 45.54 (NHCH2CH2CH2CH3), 
80.22 ((CH3)3-C-O), 98.02 (C8a), 120.13 (C1a), 
143.00 (C3a), 148.91 (C2), 149.20 (C9), 151.77 
(C4a), 156.50 (C6), 160.74 (HNCOO), 163.68 (C8). 
 
5-Amino-4-(1-methylsulfanyl-2,2-dicyanovinyl)-1-
(2'-deoxy-3',5'-di-O-p-toluoyl-b-D-ribofuranosyl) 
imidazole 30 
1-(2'-Deoxy-3',5'-di-O-p-toluoyl-b-D-erythro-
pentofuranosyl)-5-nitroimidazole 2999 (3.00 g, 6.4 
mmol), and 5% Pd/C catalyst (3.00 g) were placed in 
dry THF (120 mL) and the mixture was hydrogenated 
at rt and atmospheric pressure, with vigorous stirring 
(2 h). The solution was filtered through dry celite, 
under argon, into a flask containing 2-(bis-
methylsulfanyl-methylene)-malononitrile 9 (5.50 g, 
32.3 mmol). The celite was washed with a further 
portion of THF (120 mL). The reaction was stirred at 
50 oC, under argon, overnight giving a dark brown 
solution. The mixture was evaporated to dryness and 
the residue treated with liquid nitrogen-chilled EtOAc 
(200 mL). The solution was then filtered to give the 
crude product which was purified by column chroma-
tography eluting with CH2Cl2, to remove excess start-
ing material, and then with 1% MeOH in CH2Cl2. The 
relevant fractions were combined and evaporated to 
dryness to give the amine 30 (0.53 g, 15%) brown 
crystalline solid; mp 98-100 oC. 
IR (KBr): 752, 1102, 1178, 1209, 1270, 1311, 1377, 
1449, 1486, 1508, 1544, 1578, 1611, 1720, 2209, 
2923, 3035, 3329 cm-1. 
1H NMR (d6-DMSO): d = 2.30 (s, 3H, S-CH3), 2.39 
(s, 3H, Ar-CH3), 2.41 (s, 3H, Ar-CH3), 2.70 (m, 1H, 
2’-CH), 2.88 (m, 1H, 2’-CH), 4.54 (m, 3H, 5’-CH2 
and 4’-CH), 5.63 (d, J = 4.0 Hz, 1H, 3’-CH), 6.19 (m, 
1H, 1’-CH), 7.18 (br s, 2H, NH2), 7.34 (d, J = 8.0 Hz, 
2 x 2H, Ar-H), 7.38 (d, J = 8.0 Hz, 2H, 2 x Ar-H), 
7.79 (s, 1H, imidazole(2)-H), 7.88 (d, J = 8.0 Hz, 2H, 
2 x Ar-H), 7.97 (d, J = 8.0 Hz, 2H, 2 x Ar-H). 
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13C NMR (d6-DMSO): d = 17.61 (S-CH3), 21.09 (2 x 
Ar-CH3), 36.08 (C2’), 64.02 (C5’), 64.40 (C3’), 74.80 
(C(CN)2), 81.59 (C1’), 82.73 (C4’), 114.16 (C4-
imidazole), 126.41 (2 x CN), 129.22 (2 x ArC), 
129.30 (4 x ArC), 129.45 (4 x ArC), 132.29 (C2-
imidazole), 143.82 (C-CH3), 144.04 (C-CH3), 145.42 
(C5-imidazole), 165.08 (C=O), 165.38 (C=O), 167.13 
(C=C(CN)2). 
MS (EI): m/z (%) = 558 (5) [M+H+], 234 (52), 219 
(10), 179 (13), 154 (43), 153 (15), 119 (27), 115 (58), 
98 (100), 81 (85). 
Anal. Calcd. for C29H27N5O5S (557.62): C, 62.47; H, 
4.88; N, 12.56. 
Found: C, 62.30; H, 4.65, N, 12.26. 
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